Entering 2026 with SOLIS solar systems shipping, expanding B2B and retail momentum, active EV OEM discussions, and major ...
Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain ...
For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut ...
Tokyo, Japan and Cambridge, UK, 13 January 2026 - Nxera Pharma Co., Ltd. ('Nxera” or 'the Company”; TSE 4565) notes that ...
Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and emerging technology products, today announced that it has secured initial commercial commitments from ...
Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology ...
After a whirlwind of conference news Monday, we're doing it all over again with Day 2 of the J.P. Morgan Healthcare ...
Pimicotinib was independently developed by Abbisko Therapeutics and has been licensed to Merck KGaA, Darmstadt, Germany, for worldwide commercialization. In December 2025, pimicotinib was approved by ...
Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback